Multicenter nation-wide retrospective study in patients with idiopathic interstitial pneumonias associated with advanced primary lung cancer

Multicenter nation-wide retrospective study in patients with idiopathic interstitial pneumonias associated with advanced primary lung cancer - Treatment in patients with idiopathic interstitial pneumonias associated with advanced lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018227

Enrollment

1500

Registered

2015-09-01

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic interstitial pneumonias associated with advanced stage primary lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Idiopathic interstitial pneumonia in patients with advanced stage primary lung cancer, who received chemotherapy or best supportive care as the first line treatment. Retrospective, medical record basis study.

Exclusion criteria

Exclusion criteria: Not fulfill the criteria listed above

Design outcomes

Primary

Measure	Time frame
The primary outcome is to propose the most safe and effective regimens as the first and second lines chemotherapy.	—

Secondary

Measure	Time frame
1) The secondary outcome is to identify the risk factors for developing the acute exacerbation during the treatments. 2) The next outcome is to demonstrate the clinical conditions in patients who sellected the best supportive care as the first line treatment.	—

Countries

Japan

Contacts

Public ContactAtsushi Miyamoto, MD

Toranomon Hospital Dep. of respiratory center, respiratory medicine

atsushimotty@gmail.com03-3588-1111

Outcome results